Pharmacogenetic Approach for the Prevention of Rivaroxaban’s ADRs: A Systematic Review and Meta-Analysis
Introduction. Pharmacogenetics is a potential approach that can be applied to decline the burden of rivaroxaban’s ADRs. The current systematic review and meta-analysis aim to identify genetic variants correlated with rivaroxaban exposure and evaluate their importance. Methods. We systematically sear...
Saved in:
| Main Authors: | Parham Mardi, Bahareh Abbasi, Arman Shafiee, Tara Afsharmoghaddam |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Genetics Research |
| Online Access: | http://dx.doi.org/10.1155/2023/6105320 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenetics and pharmacokinetics of rivaroxaban in patients with atrial fibrillation and chronic kidney disease
by: N. A. Shatalova, et al.
Published: (2023-11-01) -
Systematic Review of Pharmacogenetics of Immunosuppressants in Heart Transplantation
by: Juan Eduardo Megías-Vericat, et al.
Published: (2025-06-01) -
Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
by: A T Cohen, et al.
Published: (2016-01-01) -
Impact of pharmacogenetics on aspirin resistance: a systematic review
by: Gustavo Figueiredo da Silva, et al.
Published: (2023-01-01) -
Incorporating ADR in Canadian Civil Litigation
by: Deborah Lynn Zutter
Published: (2001-01-01)